TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06653387: A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotec

Sponsor: InspireMD · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 50 pts

Competing Trials Overlap

7 Active Trials

Excess Burn Exposure

$1,261,600

Rescue Site Savings

+$830,000

Unlock Full NCT06653387 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06653387 Rescue Dossier →